Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Clinical innovation and scientific progress in GLP-1 medicine (Nov 2025)
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
The SAMP1/Yit mouse: another step closer to modeling human inflammatory bowel disease
Warren Strober, Kazuhiko Nakamura, Atsushi Kitani
Warren Strober, Kazuhiko Nakamura, Atsushi Kitani
View: Text | PDF
Commentary

The SAMP1/Yit mouse: another step closer to modeling human inflammatory bowel disease

  • Text
  • PDF
Abstract

Authors

Warren Strober, Kazuhiko Nakamura, Atsushi Kitani

×

Figure 1

Options: View larger image (or click on image) Download as PowerPoint
Routes to mucosal inflammation. Antigens stimulating the mucosal immune ...
Routes to mucosal inflammation. Antigens stimulating the mucosal immune system are presented via dendritic cells (DC; light blue) in the Peyer’s patches. In response, effector T cells (red) produce either IL-4 or IFN-γ and provide defense, whereas regulatory T cells (yellow) produce IL-10 and/or TGF-β and regulate the effector cells. In the normal, uninflamed intestine, the responses by effector cells and regulatory cells are balanced. T-cell development under these conditions (top panel) allows for host defense without inflammation. In the generalized model of mucosal inflammation, type 1 (middle panel), genetic factors lead to an excessive effector cell response that overwhelms or inhibits regulatory responses; inflammation ensues. Conversely, in the generalized model of mucosal inflammation, type 2 (bottom panel), the effector response is intrinsically normal but genetic factors lead to an attenuated regulatory response and, once again, to inflammation. While certain genetic factors must be present for disease to develop, environmental triggers must also be present to bring these genetic factors into play.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts